RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
基于计算机的图像分析是分析鳞状膀胱癌免疫拓扑结构的高效工具。具有强 PD-L1 表达的热肿瘤-免疫表型可能构成鳞状膀胱癌临床成功 ICI 治疗的有前景亚组,值得进一步研究。
免疫检查点抑制剂(ICI)疗法已成为膀胱癌的一种可行治疗策略。然而,治疗反应存在差异,需要改进的生物标志物。关键的是,免疫细胞的特征仍研究不足,尤其是在鳞状分化膀胱癌(sq-BLCA)中。在此,我们定量分析了sq-BLCA的肿瘤免疫表型,并将其与PD-L1表达和FGFR3突变状态相关联。
组织芯片(TMA)包含 n = 68 例非血吸虫病相关纯鳞状细胞癌(SCC)和 n = 46 例伴鳞状分化的混合型尿路上皮癌(MIX),对其进行 CD3、CD4、CD8、CD56、CD68、CD79A、CD163、Ki67、穿孔素和氯乙酸酯酶染色的免疫组化检测。通过数字图像分析进行定量图像评估。
免疫浸润在间质中通常高于肿瘤区域。B细胞(CD79A)几乎仅见于间质区域(sTILs),T淋巴细胞和巨噬细胞也存在于肿瘤细胞区域(iTILs),而NK 细胞(CD56)在任何区域几乎均缺失。肿瘤-免疫表型分布因免疫细胞亚群而异,然而,热肿瘤-免疫表型(肿瘤区域免疫细胞高密度)常见于CD8+ T细胞(33%),尤其是穿孔素+淋巴细胞(52.2%)和CD68+巨噬细胞(37.6%)。穿孔素+CD8淋巴细胞预测sq-BLCA总生存期改善,而高PD-L1表达(CPS ≥ 10)与较高的CD3+、CD8+和CD163+免疫细胞密度及肿瘤细胞高Ki67(密度)显著相关。此外,PD-L1表达与CD3+/CD4+、CD3+/CD8+和CD68+/CD163+热肿瘤-免疫表型呈正相关。FGFR3突变状态与CD8+、穿孔素+和CD79A+淋巴细胞密度呈负相关。
Tissue microarrays (TMA) of n = 68 non-schistosomiasis associated pure squamous cell carcinoma (SCC) and n = 46 mixed urothelial carcinoma with squamous differentiation (MIX) were subjected to immunohistochemistry for CD3, CD4, CD8, CD56, CD68, CD79A, CD163, Ki67, perforin and chloroacetate esterase staining. Quantitative image evaluation was performed via digital image analysis.
Immune infiltration was generally higher in stroma than in tumour regions. B-cells (CD79A) were almost exclusively found in stromal areas (sTILs), T-lymphocytes and macrophages were also present in tumour cell areas (iTILs), while natural killer cells (CD56) were nearly missing in any area. Tumour-immune phenotype distribution differed depending on the immune cell subset, however, hot tumour-immune phenotypes (high density of immune cells in tumour areas) were frequently found for CD8 + T-cells (33%), especially perforin + lymphocytes (52.2%), and CD68 + macrophages (37.6%). Perforin + CD8 lymphocytes predicted improved overall survival in sq-BLCA while high PD-L1 expression (CPS ≥ 10) was significantly associated with higher CD3 + , CD8 + and CD163 + immune cell density and high Ki67 (density) of tumour cells. Furthermore, PD-L1 expression was positively associated with CD3 + /CD4 + , CD3 + /CD8 + and CD68 + /CD163 + hot tumour-immune phenotypes. FGFR3 mutation status was inversely associated with CD8 + , perforin + and CD79A + lymphocyte density.
Computer-based image analysis is an efficient tool to analyse immune topographies in squamous bladder cancer. Hot tumour-immune phenotypes with strong PD-L1 expression might pose a promising subgroup for clinically successful ICI therapy in squamous bladder cancer and warrant further investigation.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。